A clinic-pathological prospective study of operable carcinoma breast

Abstract

Background: Cancer breast is the leading cause of site-specific cancer-related death next to cancer cervix for women aged 20-59 years. Early diagnosis and treatment will reduce the morbidity and mortality of the disease and thus prolongs the survival of the patient. The patient usually present in the later stages of disease, due to the lack of awareness. This study aims at studying the various type of clinical and pathological patterns of presentation of operable carcinoma breast in a tertiary care centre.Methods: 50 patients with Carcinoma Breast, admitted in Government Royapettah Hospital were studied. It was a cross-sectional prospective study performed from January 2016 to October 2017.Results: The average age of occurrence of operable carcinoma breast is 48.54 years. One patient had a positive family history. Lump (100%) is the most commonest presentation. 98% of the study population had Infiltrating ductal carcinoma as HPE report. In my study population 56 % of had stage II disease. Patient with Early breast cancer underwent surgery followed by adjuvant chemotherapy, hormonal therapy, and radiotherapy. Patient with stage III disease undergoes neoadjuvant chemotherapy followed by surgery, then adjuvant chemotherapy, hormonal therapy, radiotherapy.Conclusions: The incidence of operable carcinoma breast is more common among middle-aged groups. The commonest presenting complaint is a lump and commonest histopathological type is infiltrating ductal carcinoma. Multimodality modality manage is the optimum treatment adopted. Routine screening mammography and by the health awareness programme carcinoma breast, nowadays, detected at an earlier stage.